Evidence map›Paper›PMID 35013023›Full record

ArticleJournal of atherosclerosis and thrombosis2022

The Contribution of Inflammation to Stroke Recurrence Attenuates at Low LDL-C Levels.

Xing Zhang, Wei Lv, Jie Xu, Jiejie Li, Yuesong Pan, Hongyi Yan, Hao Li, Zixiao Li, Xia Meng, Yongjun Wang

Open access · diamondAbstract read
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Xing ZhangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Wei LvDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Jie XuDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Jiejie LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Yuesong PanChina National Clinical Research Center for Neurological Diseases.
Hongyi YanChina National Clinical Research Center for Neurological Diseases.
Hao LiChina National Clinical Research Center for Neurological Diseases.
Zixiao LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Xia MengDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
Yongjun WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University.
National Clinical Research Center for Digestive Diseases · CNCapital Medical University · CNBeijing Tian Tan Hospital · CNCenter for Excellence in Brain Science and Intelligence Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsResidual inflammation risk refers to inflammation that still increases the risk of cardiovascular disease after the level of low-density lipoprotein cholesterol (LDL-C) reached the target (<70 mg/dL). However, whether inflammation is still an important issue even if very low LDL-C levels have been achieved remains unclear. This study aimed to investigate the contribution of inflammation to stroke recurrence on different LDL-C levels following ischemic stroke (IS) or transient ischemic attack (TIA).

methodsA total of 10499 IS/TIA patients whose LDL-C and high-sensitivity C-reactive protein (hsCRP) were measured were selected from the Third China National Stroke Registry. The cutoff values were set to 25, 35, 45, 55, 70, and 100 mg/dL for LDL-C, whereas the threshold values of hsCRP and interleukin-6 (IL-6) were 2 mg/L and 1.65 ng/L, respectively. Based on each group of LDL-C, Cox regressions were conducted to investigate the associations between inflammation and recurrent stroke within 1 year.

resultsThe associations between baseline hsCRP levels and stroke recurrence were non-significant in groups with LDL-C <55 mg/dL (P>0.05). After stratification by baseline LDL-C of 55 mg/dL, hsCRP ≥ 2 mg/L (10.9% versus 7.5%, P<0.0001) and IL-6 ≥ 1.65 ng/L (9.8% versus 7.4%, P=0.0002) were found to be related to a high incidence of recurrent IS among patients with LDL-C ≥ 55 mg/dL; however, no associations were observed among patients with LDL-C <55 mg/dL. Compared with low inflammation (both hsCRP <2 mg/L and IL-6 <1.65 ng/L), high inflammation (both hsCRP ≥ 2 mg/L and IL-6 ≥ 1.65 ng/L) was significantly associated with stroke recurrence when LDL-C ≥ 55 mg/dL (adjusted HR 1.38, 95% CI 1.10-1.74), whereas this association was not observed when LDL-C <55 mg/dL (adjusted HR, 0.72; 95% CI, 0.41-1.25).

conclusionFor IS/TIA patients, the contribution of inflammation to stroke recurrence seems to be attenuated at a low level of LDL-C.

Indexed as

Ischemic Attack, TransientStrokeCholesterol, LDLC-Reactive ProteinHumansInflammationInterleukin-6Risk FactorsCholesterol, LDLC-Reactive ProteinInterleukin-6High-sensitivity C-reactive proteinInflammationInterleukin-6Low-density lipoprotein cholesterolStroke recurrence

Identifiers

PMID35013023
PMCPMC9623073
OpenAlexW4206758133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.